ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...1516171819202122232425...129130»
  • ||||||||||  albendazole / Generic mfg.
    Trial completion, Trial completion date, Combination therapy:  DOLF IDA/Oncho: Safety and Efficacy of IDA for Onchocerciasis (clinicaltrials.gov) -  Dec 14, 2022   
    P2,  N=154, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2023 --> Jun 2022
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Chylous Ascites as the Main Clinical Symptom of a Strongyloides stercoralis Infection in an Immigrant from Bosnia-Herzegovina. (Pubmed Central) -  Dec 13, 2022   
    Hence, IDX184 may also be considered as a potential inhibitor of RdRp after clinical study.Communicated by Ramaswamy H. Sarma. In the appropriate setting, chronic parasitic diseases should be considered in patients presenting with unusual symptoms.Alcohol misuse, as a form of immunosuppression, can particularly distract from other underlying conditions presenting with similar signs and symptoms.This case study may represent the first publication of strongyloidiasis manifesting as chylous ascites.
  • ||||||||||  ivermectin oral / Generic mfg., levamisole / Generic mfg.
    Review, Journal:  Essential Oils as Novel Anthelmintic Drug Candidates. (Pubmed Central) -  Dec 12, 2022   
    However, this has led to the development of resistance against several of the most common drugs, such as levamisole, ivermectin and thiabendazole...Multiple review articles have been published on the uses of a single plant and its extracts that only briefly touch upon their anthelmintic activity. This review aims to provide a detailed overview of essential oils and their components as anthelmintic treatment against a wider variety of helminths.